Lack Of Asbestos 'Biomarkers' Looms Over J&J Talc Trial
The purported lack of so-called asbestos "biomarkers" in four mesothelioma victims looms over a New Jersey state trial over accusations that they developed the fatal disease by using Johnson & Johnson's...To view the full article, register now.
Already a subscriber? Click here to view full article